Skip to main content

Karuna Therapeutics, Inc.

KRTXDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001771917

Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Karuna Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of KRTX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders171178+7
Shares29.3M29.5M+231.5K (+0.8%)
Value$3.83B$3.73B−$93.4M (−2.4%)

New holders (26)

Institutions that held Karuna Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to KRTX in Q1 2022
InstitutionSharesValue% of portfolio
Cormorant Asset Management, LP150,000$19.0M1.46%
Ghost Tree Capital, LLC60,000$7.61M3.77%
Ikarian Capital, LLC50,000$6.34M1.93%
Walleye Capital LLC30,406$3.85M0.11%
Altium Capital Management LP21,000$2.66M0.93%
Nicholas Investment Partners, LP20,189$2.56M0.18%
MPM Oncology Impact Management LP20,000$2.54M0.68%
Endurant Capital Management LP15,342$1.95M0.59%
Schonfeld Strategic Advisors LLC10,400$1.32M0.01%
Affinity Asset Advisors, LLC7,500$951.0K0.38%
Boothbay Fund Management, LLC6,130$777.0K0.03%
Graham Capital Management, L.P.4,515$572.0K0.03%
SG3 Management, LLC4,250$539.0K0.15%
Amalgamated Financial Corp.3,634$461.0K0.00%
Jump Financial, LLC3,400$431.0K0.02%
E Fund Management Co., Ltd.2,607$331.0K0.01%
Algert Global LLC2,141$271.0K0.02%
Engineers Gate Manager LP2,020$256.0K0.01%
OneAscent Wealth Management LLC1,945$247.0K0.12%
Walleye Trading LLC1,859$236.0K0.00%
Lazard Asset Management LLC688$87.0K0.00%
FourThought Financial, LLC0$27.0K0.00%
Washington Trust Advisors, Inc.19$2.00K0.00%
Massmutual Trust Co FSB5$1.00K0.00%
CWM, LLC4$1.00K0.00%
TCWP LLC5$00.00%

Sold out (19)

Institutions that held Karuna Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.